# FDA Inspection 986013 - KRS Global Biotechnology, Inc - August 31, 2016

Source: https://www.keypedia.com/records/fda_inspections/krs-global-biotechnology-inc/cd85867a-e3de-43ab-81cd-ce981ec9d9d8
Source feed: FDA_Inspections

> FDA Inspection 986013 for KRS Global Biotechnology, Inc on August 31, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 986013
- Company Name: KRS Global Biotechnology, Inc
- Inspection Date: 2016-08-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1099535 - 2019-08-14](https://www.keypedia.com/records/fda_inspections/krs-global-biotechnology-inc/1804565c-79a0-475b-b9d0-5b306dd6f8d8)
- [FDA Inspection 1029456 - 2017-10-23](https://www.keypedia.com/records/fda_inspections/krs-global-biotechnology-inc/5a8d42af-0af0-4dc1-a333-681c97ef4b8e)
- [FDA Inspection 870308 - 2014-03-17](https://www.keypedia.com/records/fda_inspections/krs-global-biotechnology-inc/a7dcb658-3773-4855-8a12-dbd54ea9b9ae)

Company: https://www.keypedia.com/companies/krs-global-biotechnology-inc/334c87d8-3093-492d-858e-ba1665e860e6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c